
Sign up to save your podcasts
Or


The pharmaceutical industry is pursuing what some consider to be the holy grail: developing and licensing the first drug that slows the body's natural aging process.
Writer: Jon Ungoed-Thomas
Producer: Casey Magloire
Host: Tomini Babs
Executive Producer: Rebecca Moore
Hosted on Acast. See acast.com/privacy for more information.
By The Observer4.6
1515 ratings
The pharmaceutical industry is pursuing what some consider to be the holy grail: developing and licensing the first drug that slows the body's natural aging process.
Writer: Jon Ungoed-Thomas
Producer: Casey Magloire
Host: Tomini Babs
Executive Producer: Rebecca Moore
Hosted on Acast. See acast.com/privacy for more information.

409 Listeners

281 Listeners

837 Listeners

150 Listeners

1,033 Listeners

294 Listeners

168 Listeners

265 Listeners

3 Listeners

26 Listeners

3,524 Listeners

70 Listeners

3,582 Listeners

1,208 Listeners

1,174 Listeners

57 Listeners

394 Listeners

46 Listeners

37 Listeners

486 Listeners

942 Listeners

1 Listeners

16 Listeners

47 Listeners

4 Listeners

172 Listeners

6 Listeners

12 Listeners

14 Listeners

84 Listeners

6 Listeners